AU7363691A - Methods for treating interleukin-1 mediated diseases - Google Patents

Methods for treating interleukin-1 mediated diseases

Info

Publication number
AU7363691A
AU7363691A AU73636/91A AU7363691A AU7363691A AU 7363691 A AU7363691 A AU 7363691A AU 73636/91 A AU73636/91 A AU 73636/91A AU 7363691 A AU7363691 A AU 7363691A AU 7363691 A AU7363691 A AU 7363691A
Authority
AU
Australia
Prior art keywords
methods
mediated diseases
treating interleukin
interleukin
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU73636/91A
Other versions
AU649245B2 (en
Inventor
David F. Carmichael
Christopher G. Smith
Robert C. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU7363691A publication Critical patent/AU7363691A/en
Application granted granted Critical
Publication of AU649245B2 publication Critical patent/AU649245B2/en
Assigned to AMGEN, INC. reassignment AMGEN, INC. Request to Amend Deed and Register Assignors: SYNERGEN, INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU73636/91A 1990-04-02 1991-03-20 Methods for treating interleukin-1 mediated diseases Expired AU649245B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US50274590A 1990-04-02 1990-04-02
US502745 1990-04-02
US52421090A 1990-05-16 1990-05-16
US524210 1990-05-16
US53055390A 1990-05-29 1990-05-29
US530553 1990-05-29

Publications (2)

Publication Number Publication Date
AU7363691A true AU7363691A (en) 1991-10-03
AU649245B2 AU649245B2 (en) 1994-05-19

Family

ID=27414214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73636/91A Expired AU649245B2 (en) 1990-04-02 1991-03-20 Methods for treating interleukin-1 mediated diseases

Country Status (5)

Country Link
JP (3) JP2609485B2 (en)
KR (1) KR920005691A (en)
AU (1) AU649245B2 (en)
CA (1) CA2039458A1 (en)
IL (1) IL97641A0 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997028828A1 (en) * 1996-02-09 1997-08-14 Amgen Boulder Inc. Composition comprising interleukin-1 inhibitor and controlled release polymer
US5739282A (en) * 1994-10-13 1998-04-14 Applied Research Systems Ars Holding N.V. Interleukin-1 antagonist
US5837495A (en) * 1994-10-13 1998-11-17 Applied Research Systems Ars Holding N.V. DNA encoding interleukin-1 antagonist
AU736876B2 (en) * 1996-12-06 2001-08-02 Amgen, Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
EP2087908A1 (en) 2001-06-26 2009-08-12 Amgen, Inc. Antibodies to opgl
EP2277543A1 (en) 2002-09-06 2011-01-26 Amgen, Inc Therapeutic anti-IL-1R1 monoclonal antibody
WO2013170636A1 (en) 2012-05-18 2013-11-21 爱德迪安（北京）生物技术有限公司 Protein and protein conjugate for diabetes treatment, and applications thereof
EP2816060A1 (en) 2005-11-14 2014-12-24 Amgen Inc. Rankl antibody-PTH/PTHRP chimeric molecules
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
WO2020035482A1 (en) 2018-08-13 2020-02-20 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
JP3623501B2 (en) * 1991-10-31 2005-02-23 ザ ビクトリア ユニバーシティ オブ マンチェスター Treatment of neurological conditions with interleukin-1 inhibitory compounds
WO1996031211A1 (en) * 1995-04-07 1996-10-10 Teijin Limited Protective agent for organ or tissue
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
EP1712239A3 (en) * 2000-05-12 2007-08-22 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
KR100733025B1 (en) * 2006-05-24 2007-06-28 윤인석 A structure of bottle cap with safety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02223597A (en) * 1988-10-24 1990-09-05 Otsuka Pharmaceut Co Ltd Interleukin-1beta derivative
JP2863265B2 (en) * 1989-05-19 1999-03-03 ハダサ メディカル オーガニゼーション Interleukin 1 inhibitor

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739282A (en) * 1994-10-13 1998-04-14 Applied Research Systems Ars Holding N.V. Interleukin-1 antagonist
US5837495A (en) * 1994-10-13 1998-11-17 Applied Research Systems Ars Holding N.V. DNA encoding interleukin-1 antagonist
AU724960C (en) * 1996-02-09 2002-08-15 Swedish Orphan Biovitrum Ab (Publ) Composition comprising interleukin-1 inhibitor and controlled release polymer
AU724960B2 (en) * 1996-02-09 2000-10-05 Swedish Orphan Biovitrum Ab (Publ) Composition comprising interleukin-1 inhibitor and controlled release polymer
WO1997028828A1 (en) * 1996-02-09 1997-08-14 Amgen Boulder Inc. Composition comprising interleukin-1 inhibitor and controlled release polymer
CZ299025B6 (en) * 1996-02-09 2008-04-02 Amgen Inc. Pharmaceutical composition and use thereof
AU736876B2 (en) * 1996-12-06 2001-08-02 Amgen, Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6733753B2 (en) * 1997-02-10 2004-05-11 Amgen Inc. Composition and method for treating inflammatory diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
EP2087908A1 (en) 2001-06-26 2009-08-12 Amgen, Inc. Antibodies to opgl
EP3492100A1 (en) 2001-06-26 2019-06-05 Amgen Inc. Antibodies to opgl
EP2277543A1 (en) 2002-09-06 2011-01-26 Amgen, Inc Therapeutic anti-IL-1R1 monoclonal antibody
EP3020414A1 (en) 2002-09-06 2016-05-18 Amgen, Inc Therapeutic anti-il-1r1 monoclonal antibody
EP2816060A1 (en) 2005-11-14 2014-12-24 Amgen Inc. Rankl antibody-PTH/PTHRP chimeric molecules
WO2013170636A1 (en) 2012-05-18 2013-11-21 爱德迪安（北京）生物技术有限公司 Protein and protein conjugate for diabetes treatment, and applications thereof
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
WO2020035482A1 (en) 2018-08-13 2020-02-20 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof

Also Published As

Publication number Publication date
JPH11269089A (en) 1999-10-05
AU649245B2 (en) 1994-05-19
CA2039458A1 (en) 1991-10-03
JP2609485B2 (en) 1997-05-14
JP2942196B2 (en) 1999-08-30
JPH05112462A (en) 1993-05-07
IL97641A0 (en) 1992-06-21
KR920005691A (en) 1992-04-03
JPH09118632A (en) 1997-05-06

Similar Documents

Publication Publication Date Title
AU616091B2 (en) Treatment process
AU624464B2 (en) Skin treatment method
AU7629594A (en) Imidazoles for treating cytokine mediated disease
AU2293888A (en) Dosage form for treating cardiovascular diseases
AU5045190A (en) Filter apparatus
AU7363691A (en) Methods for treating interleukin-1 mediated diseases
AU5521290A (en) Induction-based assistive listening system
AU4524889A (en) Method for the treatment of periodontal disease
AU5869990A (en) Means for surgical treatment
AU3604989A (en) Depilation apparatus
AU6596590A (en) Deoxyfluoronucleoside process
AU6386390A (en) Therapeutic necleosides
AU7438691A (en) Nut harvesting apparatus
AU6798490A (en) Ocular treatment apparatus
AU6735490A (en) Process for chlorofluoropropanes
AU5972190A (en) Halogen-exchange process
AU613355B2 (en) Method for treating skin diseases
AU7213291A (en) Straw treatment apparatus
AU7467891A (en) Process for imparting knowledge
AU3605089A (en) Depilation apparatus
AU7294491A (en) Labdanes and process for their preparation
AU9021291A (en) Adjustable diaper
AU630316B2 (en) Epilation apparatus
AU6598490A (en) Electro-surgery apparatus
AU4971490A (en) Date-stamping apparatus